» Articles » PMID: 29470821

Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries

Overview
Specialty Pharmacology
Date 2018 Feb 23
PMID 29470821
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study describes the first empirical head-to-head comparison of EQ-5D-3L (3L) and EQ-5D-5L (5L) value sets for multiple countries.

Methods: A large multinational dataset, including 3L and 5L data for eight patient groups and a student cohort, was used to compare 3L versus 5L value sets for Canada, China, England/UK (5L/3L, respectively), Japan, The Netherlands, South Korea and Spain. We used distributional analyses and two methods exploring discriminatory power: relative efficiency as assessed by the F statistic, and an area under the curve for the receiver-operating characteristics approach. Differences in outcomes were explored by separating descriptive system effects from valuation effects, and by exploring distributional location effects.

Results: In terms of distributional evenness, efficiency of scale use and the face validity of the resulting distributions, 5L was superior, leading to an increase in sensitivity and precision in health status measurement. When compared with 5L, 3L systematically overestimated health problems and consequently underestimated utilities. This led to bias, i.e. over- or underestimations of discriminatory power.

Conclusion: We conclude that 5L provides more precise measurement at individual and group levels, both in terms of descriptive system data and utilities. The increased sensitivity and precision of 5L is likely to be generalisable to longitudinal studies, such as in intervention designs. Hence, we recommend the use of the 5L across applications, including economic evaluation, clinical and public health studies. The evaluative framework proved to be useful in assessing preference-based instruments and might be useful for future work in the development of descriptive systems or health classifications.

Citing Articles

A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets.

Bailey H, Roudijk B Appl Health Econ Health Policy. 2025; .

PMID: 40069434 DOI: 10.1007/s40258-025-00954-z.


The evolution of vestibular function and health-related quality of life in bilateral vestibulopathy.

Loos E, Van Stiphout L, Lucieer F, Guinand N, Perez-Fornos A, Van Rompaey V Sci Rep. 2025; 15(1):7476.

PMID: 40033069 PMC: 11876669. DOI: 10.1038/s41598-025-92109-2.


Valuing health-related quality of life: an EQ-5D-5L value set for Morocco.

Azizi A, Boutib A, Achak D, Purba F, Rencz F, Saad E Qual Life Res. 2025; .

PMID: 40019677 DOI: 10.1007/s11136-025-03930-1.


Measuring the quality of life of patients with diabetic retinopathy in northern India: a comparison of generic and vision specific instruments.

Purohit N, Goyal A, Gupta V, Gupta P, Singh P, Prinja S Health Qual Life Outcomes. 2025; 23(1):17.

PMID: 39985016 PMC: 11846259. DOI: 10.1186/s12955-025-02340-8.


Is the Rate of Early mobilization in Hip fracture patients using Alfentanil Better than standard opioid analgesia (REHAB)? A protocol for a prospective cohort study.

Agarwal N, MacLullich A, Clement N Bone Jt Open. 2025; 6(1):53-61.

PMID: 39788153 PMC: 11717437. DOI: 10.1302/2633-1462.61.BJO-2024-0076.R1.


References
1.
Parkin D, Devlin N, Feng Y . What Determines the Shape of an EQ-5D Index Distribution?. Med Decis Making. 2016; 36(8):941-51. DOI: 10.1177/0272989X16645581. View

2.
Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S . Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan. Value Health. 2016; 19(5):648-54. DOI: 10.1016/j.jval.2016.03.1834. View

3.
Olsen J, Lamu A, Cairns J . In search of a common currency: A comparison of seven EQ-5D-5L value sets. Health Econ. 2017; 27(1):39-49. DOI: 10.1002/hec.3606. View

4.
Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goni J, Luo N . EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. Pharmacoeconomics. 2016; 34(10):993-1004. PMC: 5023738. DOI: 10.1007/s40273-016-0404-1. View

5.
Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T, Longworth L . An exploratory study to test the impact on three "bolt-on" items to the EQ-5D. Value Health. 2015; 18(1):52-60. PMC: 4309886. DOI: 10.1016/j.jval.2014.09.004. View